Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
130.66
+2.20 (1.71%)
At close: Aug 19, 2026, 4:00 PM EDT
130.76
+0.10 (0.08%)
Pre-market: Aug 20, 2026, 9:00 AM EDT
Insmed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,138 | 606.42 | 363.71 | 305.21 | 245.36 | 188.46 | |
Revenue Growth | 185.76% | 66.73% | 19.17% | 24.39% | 30.19% | 14.63% |
Cost of Revenue | 188.22 | 122.94 | 85.74 | 65.57 | 55.13 | 44.15 |
Gross Profit | 949.42 | 483.49 | 277.97 | 239.64 | 190.23 | 144.31 |
Selling, General & Admin | 893.59 | 701.17 | 461.12 | 344.5 | 265.78 | 233.67 |
Research & Development | 860.85 | 771.09 | 598.37 | 571.01 | 397.52 | 272.74 |
Amortization of Goodwill & Intangibles | 7.64 | 6 | 5.05 | 5.05 | 5.05 | 5.05 |
Operating Expenses | 1,762 | 1,478 | 1,065 | 920.56 | 668.36 | 511.47 |
Operating Income | -812.65 | -994.78 | -786.57 | -680.93 | -478.12 | -367.16 |
Interest Expense | -81.34 | -83.8 | -85.15 | -81.37 | -27.97 | -40.47 |
Interest & Investment Income | 56.54 | 60.66 | 53.31 | 42.13 | 11.08 | 0.17 |
Other Non Operating Income (Expenses) | -3.69 | -1.84 | 0.03 | 1.86 | -5.94 | -3.33 |
EBT Excluding Unusual Items | -841.13 | -1,020 | -818.38 | -718.32 | -500.95 | -410.79 |
Merger & Restructuring Charges | - | - | - | - | - | -0.6 |
Other Unusual Items | -27.97 | -251.99 | -91.68 | -28.7 | 20.8 | -25.02 |
Pretax Income | -869.11 | -1,272 | -910.07 | -747.01 | -480.15 | -436.41 |
Income Tax Expense | 6.21 | 5.03 | 3.71 | 2.56 | 1.38 | -1.76 |
Net Income | -875.31 | -1,277 | -913.77 | -749.57 | -481.53 | -434.65 |
Net Income to Common | -875.31 | -1,277 | -913.77 | -749.57 | -481.53 | -434.65 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 215 | 199 | 164 | 140 | 123 | 112 |
Shares Outstanding (Diluted) | 215 | 199 | 164 | 140 | 123 | 112 |
Shares Change | 18.73% | 21.32% | 16.81% | 14.14% | 9.74% | 14.86% |
EPS (Basic) | -4.08 | -6.42 | -5.57 | -5.34 | -3.91 | -3.88 |
EPS (Diluted) | -4.09 | -6.42 | -5.57 | -5.34 | -3.91 | -3.88 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -807.67 | -967.58 | -705.81 | -549.54 | -410.32 | -370.59 |
Free Cash Flow Per Share | -3.76 | -4.86 | -4.30 | -3.91 | -3.33 | -3.31 |
Gross Margin | 83.45% | 79.73% | 76.43% | 78.52% | 77.53% | 76.57% |
Operating Margin | -71.43% | -164.04% | -216.27% | -223.10% | -194.87% | -194.82% |
Profit Margin | -76.94% | -210.54% | -251.24% | -245.59% | -196.26% | -230.63% |
Free Cash Flow Margin | -70.99% | -159.55% | -194.06% | -180.05% | -167.23% | -196.64% |
EBITDA | -794.96 | -980.46 | -777.7 | -667.64 | -465.83 | -351.9 |
EBITDA Margin | -69.88% | -161.68% | -213.82% | -218.75% | -189.86% | -186.72% |
D&A For EBITDA | 17.69 | 14.31 | 8.88 | 13.29 | 12.29 | 15.26 |
EBIT | -812.65 | -994.78 | -786.57 | -680.93 | -478.12 | -367.16 |
EBIT Margin | -71.43% | -164.04% | -216.27% | -223.10% | -194.87% | -194.82% |